Oncology Medical News about Venous thromboembolism; nonsmall cell lung cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Venous thromboembolism and nonsmall cell lung cancer
Cancer, 08/31/09

Hicks LK et al. – In patients with both early stage and advanced stage NSCLC, VTE occurred more frequently in patients who received chemotherapy (but not erlotinib or BMS–275291). In patients with advanced stage NSCLC, VTE was associated with obesity and a history of VTE. VTE was found to be prognostic in patients with advanced stage NSCLC.

<< Previous
Genitourinary Toxicity After High-Dose-Rate (HDR) Brachytherapy...

Next >>
Whole-Brain Radiotherapy With Simultaneous Integrated Boost to...

Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism
Chest, 10/08/09 Relevance Score: 69%

Prevention of Venous Thromboembolism in Thoracic and Cardiovascular Surgery
Asian Cardiovascular and Thoracic Annals, 11/20/09 Relevance Score: 68%

Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials
Circulation, 11/04/09 Relevance Score: 68%

Hematocrit and risk of venous thromboembolism in a general population. The Tromso Study
Haematologica, 10/21/09 Relevance Score: 68%

Risk factors and underlying mechanisms for venous stasis syndrome: a population-based case–control study
Vascular Medicine, 10/13/09 Relevance Score: 68%